Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction

Citations

WEB OF SCIENCE

7
Citations

SCOPUS

8

초록

With the increasing number of medications demonstrating mortality benefits in heart failure with reduced ejection fraction (HFrEF), the pharmacological treatment of HFrEF is entering a new phase. To enhance outcomes in heart failure patients through medical treatment, the choice of appropriate medications and simultaneous and rapid uptitration are critical. However, there are several challenges encountered during this medication uptitration, including issues like hypotension, fatigue, worsening renal function, and hyperkalemia. This paper addresses strategies for effectively managing these challenges to successfully reach the maximum tolerated dose in patients. Additionally, it will discuss the management of comorbidities often associated with heart failure, the importance of exercise and rehabilitation, and the significance of proper nutrition intake, in addition to guideline-directed medical therapy.

키워드

Heart failure; reduced ejection fraction; Cardiovascular disease; Guideline-directed medical therapy; Up-titration; Target dose; LEFT-VENTRICULAR FUNCTION; CHRONIC KIDNEY-DISEASE; ATRIAL-FIBRILLATION; FLUID RESTRICTION; OUTCOMES; CARVEDILOL; SURVIVAL; CARDIOMYOPATHY; LIRAGLUTIDE; INHIBITION
제목
Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
저자
Bak, Minjung; Choi, Jin-Oh
DOI
10.3904/kjim.2023.223
발행일
2023-09
유형
Review
저널명
The Korean Journal of Internal Medicine
권
38
호
5
페이지
595 ~ 606